EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Engineering Versatile Bacteria‐Derived Outer Membrane Vesicles: An Adaptable Platform for Advancing Cancer Immunotherapy

Ziheng Luo, Xiang Cheng, Bin Feng, Duoyang Fan, Xiaohui Liu, Ruyan Xie, Ting Luo, Seraphine V Wegner, Dayou Ma, Fei Chen iD, Wenbin Zeng iD

Advanced Science · 2024-09 · 11 (33)

DOI: 10.1002/advs.202400049 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, 2024-07. Verfasst von Ziheng Luo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, China. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms, Bacterial Outer Membrane. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, Scientific Research Fund of Hunan Provincial Education Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, cancer immunotherapy has undergone a transformative shift toward personalized and targeted therapeutic strategies. Bacteria‐derived outer membrane vesicles (OMVs) have emerged as a promising and adaptable platform for cancer immunotherapy due to their unique properties, including natural immunogenicity and the ability to be engineered for specific therapeutic purposes. In this review, a comprehensive overview is provided of state‐of‐the‐art techniques and methodologies employed in the engineering of versatile OMVs for cancer immunotherapy. Beginning by exploring the biogenesis and composition of OMVs, unveiling their intrinsic immunogenic properties for therapeutic appeal. Subsequently, innovative approaches employed to engineer OMVs are delved into, ranging from the genetic engineering of parent bacteria to the incorporation of functional molecules. The importance of rational design strategies is highlighted to enhance the immunogenicity and specificity of OMVs, allowing tailoring for diverse cancer types. Furthermore, insights into clinical studies and potential challenges utilizing OMVs as cancer vaccines or adjuvants are also provided, offering a comprehensive assessment of the current landscape and future prospects. Overall, this review provides valuable insights for researchers involved in the rapidly evolving field of cancer immunotherapy, offering a roadmap for harnessing the full potential of OMVs as a versatile and adaptable platform for cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyNeoplasmsBacterial Outer MembraneHumansCancer VaccinesExtracellular VesiclesBacteriaAnimals

Stichwörter der Autor:innen

bacterial engineeringcancer immunotherapyhybrid membrane vesiclesouter membrane vesiclessurface modification

Substanzen

Cancer Vaccines

Autor:innen und Institutionen

  • Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, China.
  • Hunan Key Laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Changsha, 410078, China.
  • Institute of Physiological Chemistry and Pathobiochemistry, University of Münster, 48149, Münster, Germany.

ORCID-Profile: Fei Chen, Wenbin Zeng

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Province
  • Scientific Research Fund of Hunan Provincial Education Department

Zitieren

APA

Luo, Z., Cheng, X., Feng, B., Fan, D., Liu, X., Xie, R., Luo, T., Wegner, S. V., Ma, D., Chen, F., & Zeng, W. (2024). Engineering Versatile Bacteria‐Derived Outer Membrane Vesicles: An Adaptable Platform for Advancing Cancer Immunotherapy. Advanced Science, 11(33). https://doi.org/10.1002/advs.202400049

Vancouver

Luo Z, Cheng X, Feng B, Fan D, Liu X, Xie R, et al. Engineering Versatile Bacteria‐Derived Outer Membrane Vesicles: An Adaptable Platform for Advancing Cancer Immunotherapy. Advanced Science. 2024;11(33). doi:10.1002/advs.202400049

BibTeX
@article{Luo2024,
  author = {Luo, Ziheng and Cheng, Xiang and Feng, Bin and Fan, Duoyang and Liu, Xiaohui and Xie, Ruyan and Luo, Ting and Wegner, Seraphine V and Ma, Dayou and Chen, Fei and Zeng, Wenbin},
  title = {Engineering Versatile Bacteria‐Derived Outer Membrane Vesicles: An Adaptable Platform for Advancing Cancer Immunotherapy},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {33},
  doi = {10.1002/advs.202400049}
}
Kostenlos starten →